General
India expects lion’s share of surplus US AstraZeneca vaccines as COVID-19 cases mount
India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources said as New Delhi battles a devastating surge in infections.
Key points:
-
Indian government sources say they expect India to receive the largest chunk of the US’s surplus vaccine doses
-
COVID-19 cases in India continue to rise, with the eastern state of West Bengal primed to be the country’s next big outbreak
-
India’s High Commission in Canberra responded to a news article in The Australian criticising Prime Minister Narendra Modi, calling it “malicious” and “slanderous”
On Monday, the White House said 10 million doses could be cleared for export “in coming weeks” and the rest…
-
Business14 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News19 hours ago28 years later: Grim reality for single house hunters revealed
-
Noosa News14 hours agoDangerous driving charges, Maroochydore – Sunshine Coast
-
General22 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter